Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally. Effective management ...

The latest update on iRhythm Technologies trims the fair value estimate slightly from about US$221 to roughly US$219, even as long term revenue growth assumptions edge higher from around 17.10% to ...

Would you pay for a $600 scale that informs you of your risk of hypertension and cardiac efficiency? Withings is betting big that you will.

We reviewed the best Fitbits to help you meet your 2026 fitness goals and budget, including models with basic tracking and ...

Unlike a traditional smartwatch that buzzes with notifications or pressures you to hit certain goals, WHOOP quietly works in ...

Explore the latest advancements in heart screening with AI models that enhance ECG interpretation for better patient outcomes ...

The selection of Sheik Muniru has not been an imposition, but a product of consultation and mediation,” he explained. It was, therefore, incredible how a resolved matter cont ...

Looking to turn a quick profit, the firms buy medical facilities and then unload them just a few years later, often leaving ...

Croatia has become one of several European countries to reintroduce, or consider, conscription amid concerns for national ...

These Apple AirPods (2nd Gen) come with a Lightning charging case and deliver clear sound with good bass, according to the ...

After receiving word late last month that the FDA would not be issuing a 510(k) clearance to its cable-free electrocardiogram, HeartBeam has successfully appealed the decision and now touts a green ...

HeartBeam, Inc. (BEAT) (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced that the U.S. Food and Drug ...